We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back toArtificial-Intelligence-A-Disruptive-Journey-for-Pharmacovigilance

DIA 2018 Global Annual Meeting

The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.


Artificial Intelligence: A Disruptive Journey for Pharmacovigilance

    Session Chair(s)
      Annette S. Williams, MBA, RPh

      Annette S. Williams, MBA, RPh

      • Vice President, Lifecycle Safety
      • IQVIA, United States
    Pharmacovigilance is undergoing an unprecedented amount of change. As the global regulatory environment becomes more complex, PV departments are simultaneously faced with ever increasing volumes and varieties of safety data further stretching already limited resources. How can PV units become proactive and patient centric if they are overburdened by highly labor intensive processes? The rapidly evolving world of artificial intelligence and machine learning holds significant promise. This session will explore the real life journey of several organizations engaged in adopting cognitive computing across their PV landscape. Key considerations including how to initiate an automation odyssey, identifying targets for cognitive computing, the role of subject matter experts, and the impact of positive disruption will be explored.
    Learning Objective : Understand the in depth process for training cognitive systems through a practical example like MedDRA coding, including data type, volume and quality and challenges to prepare for Outline Subject Matter Expertise requirements needed to train a cognitive system along with the iterative training process Relay the ongoing training that may be required, expected results, reasons, and process
    Speaker(s)
      Cartic  Ramakrishnan, PhD

      Training Artificial Intelligent System for Pharmacovigilance: Practical Considerations and Guidance

      Cartic Ramakrishnan, PhD

      • Senior Technical Staff Member, Lead Cognitive Scientist, Life Sciences
      • IBM Watson Health, United States
      Glenn  Carroll, MBA

      The Future of Pharmacovigilance After Full Industry Disruption from Cognitive Automation

      Glenn Carroll, MBA

      • Principal, Strategy and Operations, Life Sciences
      • Deloitte Consulting, United States
      Caroline  Rosewell, MBA

      Our Journey Toward Touchless Case Management

      Caroline Rosewell, MBA

      • Senior Director, Global Patient Safety, Clinical Case Management
      • Eli Lilly and Company, United States